{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-068530","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2025-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.117014+00:00","generated_at":"2026-05-18T05:59:42.945844+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Gain Therapeutics prices $7M public offering of common stock and warrants","bullets":["Offering of 4,501,640 common shares and warrants to purchase 2,250,820 shares at $3.11 per set.","Gross proceeds of $7.0M; net proceeds expected ~$6.3M after underwriting fees and expenses.","Proceeds to fund clinical development of lead candidate GT-02287 for GBA1 Parkinson's disease.","Warrants exercisable at $1.65 per share, immediately exercisable, expire in 5 years.","Newbridge Securities sole book-runner; closing expected July 17, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-068530","json":"https://secwatch.observer/filing/0001104659-25-068530.json","markdown":"https://secwatch.observer/filing/0001104659-25-068530.md","text":"https://secwatch.observer/filing/0001104659-25-068530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465925068530/0001104659-25-068530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465925068530/tm2521066d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:59:42.945844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}